Effects of Intravitreal Aflibercept and Ranibizumab on Retinal Vessel Diameter Measured Using Fluorescein Angiography

Acta Ophthalmologica - United States
doi 10.1111/aos.13561
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Systemic Pharmacokinetics and Pharmacodynamics of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab

Retina
MedicineOphthalmology
2017English

Long-Term Effects of Intravitreal Ranibizumab Treatment on Retinal Ganglion Cell Complex and Choroidal Thickness

New Frontiers in Ophthalmology
2018English

Intravitreal Aflibercept for Choroidal Neovascularization Secondary to Angioid Streaks in a Non-Responder to Intravitreal Ranibizumab

International Medical Case Reports Journal
Medicine
2018English

Hydrodynamic Radii of Ranibizumab, Aflibercept and Bevacizumab Measured by Time-Resolved Phosphorescence Anisotropy

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2016English

Feature Extraction Method of Retinal Vessel Diameter

2018English

Early Changes in Retinal Thickness When Using Intravitreal Ranibizumab for Age‐related Macular Degeneration

Acta Ophthalmologica
MedicineOphthalmology
2018English

Fluorescein Angiography to Estimate Normal Peripheral Retinal Nonperfusion in Children

Journal of AAPOS
Child HealthOphthalmologyPediatricsPerinatology
2012English

Clinical Effects and Safety of Treating Diabetic Macular Edema With Intravitreal Injection of Ranibizumab Combined With Retinal Photocoagulation

Therapeutics and Clinical Risk Management
2016English

Pss34 - Cost-Effectiveness of Intravitreal Aflibercept Versus Ranibizumab in the Treatment of Diabetic Macular Edema in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy